Dyslexia Clinical Trials 2022

Browse 8 Dyslexia Medical Studies Across 7 Cities

9 Dyslexia Clinics

Reviewed by Michael Gill, B. Sc.
8 Dyslexia Clinical Trials Near Me
Nashville, TN
Montreal, Canada
Columbus, OH
Boston, MA
More Trial Locations
An interactive map to display trial locations for Vanderbilt University Medical Center, McGill University, The Ohio State University, MGH Institute of Health Professions, and 4 more locations.
Most Popular References for Dyslexia Clinical Trials
Frequency
Citation
1
Torgesen, J. K., Wagner, R. K., & Rashotte, C. A. (1999). Test of word reading efficiency. Austin, TX: Pro-Ed.
Top Hospitals for Dyslexia Clinical Trials
Location
Active Dyslexia Clinical Trials
All Time Trials for Dyslexia
First Recorded Dyslexia Trial
Trials
Vanderbilt University Medical Center, Nashville, Tennessee
1
1
2022
McGill University, Montreal, Quebec
1
2
2008
The Ohio State University, Columbus, Ohio
1
1
2022
MGH Institute of Health Professions, Boston, Massachusetts
1
1
2022
Top Treatments for Dyslexia Clinical Trials
Treatment Name
Active Dyslexia Clinical Trials
All Time Trials for Dyslexia
First Recorded Dyslexia Trial
Trials
RLN and CCN real non-invasive brain stimulation intervention
1
1
2022
Set For Variability
1
1
2022
Let's Know! small-group or TierL 2 Intervention
1
1
2021
Motor Imagery and Real-Time fMRI Neurofeedback
1
1
2022
GraphoLearn reading intervention
1
1
2020
Top Cities for Dyslexia Clinical Trials
City
Active Dyslexia Clinical Trials
Top Active Site for Dyslexia Clinical Trials
Trial List
Montreal, Quebec
1
McGill University
Boston, Massachusetts
1
MGH Institute of Health Professions
West Orange, New Jersey
1
Kessler Foundation
Which phases are most popular for dyslexia clinical trials?
Senior Friendly Dyslexia Clinical Trials
Clinical Trial
Began Recruiting Date
Phase

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 23rd, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.